@id-dh.bsky.social
Risk and response adapted treatment in pediatric Epstein-Barr virus associated hemophagocytic lymphohistiocytosis
✅ Just Accepted
🔗 https://bit.ly/4nH3DIQ
✅ Just Accepted
🔗 https://bit.ly/4nH3DIQ
Risk and response adapted treatment in pediatric Epstein-Barr virus associated hemophagocytic lymphohistiocytosis
A cytokine- and clinical-based risk stratification system, combined with dynamic response assessment, enables tailored treatment for pediatric EBV-HLH pati
bit.ly
November 12, 2025 at 6:21 PM
Combined use of ibalizumab and lenacapavir for the treatment of multidrug-resistant HIV-1: A case series
✅ Just Accepted
🔗 https://bit.ly/47zMvQO
✅ Just Accepted
🔗 https://bit.ly/47zMvQO
November 12, 2025 at 6:20 PM
Fitness of SARS-CoV-2 Omicron Subvariants in Respiratory and Gastrointestinal Cell Lines as Determined by Reverse-Transcription Droplet Digital PCR and Whole-Genome Sequencing
#IDSky
#IDSky
Fitness of SARS-CoV-2 Omicron Subvariants in Respiratory and Gastrointestinal Cell Lines as Determined by Reverse-Transcription Droplet Digital PCR and Whole-Genome Sequencing
The fitness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants was determined in human epithelial and continuous cells of the respiratory and gastrointestinal tracts
bit.ly
November 3, 2025 at 5:39 PM
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
#IDSky
#IDSky
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19
We report an interim analysis of safety and efficacy of pemivibart in individuals with (cohort A) or without (cohort B) significant immunocompromise in the phase 3 CANOPY trial.
bit.ly
November 3, 2025 at 5:25 PM
Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial)
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial)
AbstractBackground. Delayed pulmonary tuberculosis (TB) diagnosis, especially with limited bronchoscopy resources, worsens outcomes and increases transmiss
bit.ly
October 29, 2025 at 3:01 PM
This directly relates to what we are currently learning in class! #PITT_IDFall25
Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosis
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47csDBA
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47csDBA
October 22, 2025 at 2:37 PM
This directly relates to what we are currently learning in class! #PITT_IDFall25
A randomized phase 1 study investigating gut microbiome changes with moxifloxacin vs. oral vancomycin: Implications for Clostridioides difficile risk
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47g3wy5
✅ Just Accepted
#IDSky
🔗 https://bit.ly/47g3wy5
October 22, 2025 at 2:35 PM
Community-Acquired Respiratory Virus Infections: A Threat to Long-Term Survivors After Allogeneic Stem Cell Transplant?
#IDSky
#IDSky
Community-Acquired Respiratory Virus Infections: A Threat to Long-Term Survivors After Allogeneic Stem Cell Transplant?
Studies on late community-acquired respiratory virus (CARV) infections in long-term allogeneic hematopoietic stem cell transplantation (allo-HCT) survivors are scarce, creating knowledge gaps on the epidemiology, risk of progression to lower respiratory tract disease (LRTD), and conditions linked...
bit.ly
October 14, 2025 at 2:23 PM
Noninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines
#IDSky
#IDSky
Validate UserNoninferiority Study of Purified Vero Rabies Vaccine—Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines
A next-generation, serum-free, highly purified Vero cell rabies vaccine, PVRV-NG2, is in development.
bit.ly
October 14, 2025 at 2:23 PM
Respiratory Virus Infections and Pulmonary Impairment after Allogeneic Hematopoietic Cell Transplantation.
✅ Just Accepted
#IDSky
🔗 https://bit.ly/485qudb
✅ Just Accepted
#IDSky
🔗 https://bit.ly/485qudb
October 8, 2025 at 11:04 PM
Time to Reappraise the Antibiotic Treatment for Methicillin-Susceptible Staphylococcus aureus Infective Endocarditis: Data From the Experimental Model
#IDSky
#IDSky
Time to Reappraise the Antibiotic Treatment for Methicillin-Susceptible Staphylococcus aureus Infective Endocarditis: Data From the Experimental Model
Daptomycin in combination with β-lactams significantly improves the activity of monotherapies in sterilizing valve vegetations and in preventing daptomycin
bit.ly
October 8, 2025 at 10:58 PM
Investigating Azithromycin Activity Against ESBL-Producing Escherichia coli Under Physiologically Relevant Conditions
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3KAnbAM
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3KAnbAM
October 3, 2025 at 1:54 AM
Maternal Inflammation Likely Drives Impaired Immune Responses to Respiratory Syncytial Virus in HIV-Exposed Uninfected Infants
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3VzGVXR
✅ Just Accepted
#IDSky
🔗 https://bit.ly/3VzGVXR
October 3, 2025 at 1:53 AM
Disparate kinetics of viable virus shedding in immunocompromised patients: SARS-CoV-2 versus influenza virus ? a prospective real-world cohort study
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48vcKbN
✅ Just Accepted
#IDSky
🔗 https://bit.ly/48vcKbN
September 26, 2025 at 2:44 PM
Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study
In this study of 172 ICU patients with influenza-related ARDS, empirical antifungal treatment was associated with reduced pulmonary aspergillosis incidence
bit.ly
September 26, 2025 at 2:43 PM
Comparing generative artificial intelligence vs. experts for detection of catheter-associated urinary tract infection (CAUTI)
✅ Just Accepted
https://bit.ly/46jNHWo
#IDSky
✅ Just Accepted
https://bit.ly/46jNHWo
#IDSky
Comparing generative artificial intelligence vs. experts for detection of catheter-associated urinary tract infection (CAUTI)
Abstract. A retrospective cohort study compared generative artificial intelligence (GenAI) vs. infection control expert for catheter-associated urinary tra
bit.ly
September 19, 2025 at 7:48 PM
Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
#IDSky
#IDSky
Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
WXSH0208 is a selective inhibitor of influenza RNA polymerase subunit, demonstrating antiviral activity in preclinical studies against influenza A and B virus infections.
bit.ly
September 19, 2025 at 7:47 PM
HIV Superinfection in Kidney Transplant Recipients With HIV Who Received Organs From Donors With HIV
#IDSky
#IDSky
HIV Superinfection in Kidney Transplant Recipients With HIV Who Received Organs From Donors With HIV
Transplantation of kidneys from donors with HIV to recipients with HIV is increasing. Among 18 recipients, there was one confirmed case of donor-derived HI
bit.ly
September 13, 2025 at 5:42 PM
Prevention of Tuberculosis in Patients Treated With Biological Therapies: Twenty Years? Experience in a Specialised Tuberculosis Clinic in a Low-prevalence Country
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Prevention of Tuberculosis in Patients Treated With Biological Therapies: Twenty Years? Experience in a Specialised Tuberculosis Clinic in a Low-prevalence Country
This study builds on previous evidence to assess the risk of tuberculosis (TB) in patients treated with biologic therapies (BioT), the role of the interferon-γ-release assay (IGRA) QuantiFERON-TB (QFT) Gold as a stand-alone screening test, and whether periodic re-testing is warranted for patients...
bit.ly
September 13, 2025 at 5:41 PM
HIV resistance to dolutegravir varies with co-administered agents
✅ Just Accepted
⭐ Editor's Choice
#IDSky
✅ Just Accepted
⭐ Editor's Choice
#IDSky
HIV resistance to dolutegravir varies with co-administered agents
We hypothesized that HIV-dolutegravir-resistance is more frequent when co-administered with nucleos(t)ides with shorter intracellular half-lives.
bit.ly
September 8, 2025 at 7:04 PM
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
#IDSky
#IDSky
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
Clinical guidelines recommend initiation of antiviral therapy as soon as possible for patients hospitalized with confirmed or suspected influenza.
bit.ly
September 8, 2025 at 7:03 PM
The Impact of Influenza on US Working-Age Adults: Exploring the Benefits of the Recombinant Influenza Vaccine
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
The Impact of Influenza on US Working-Age Adults: Exploring the Benefits of the Recombinant Influenza Vaccine
Despite universal influenza vaccine recommendation in the US, vaccination coverage rates (VCR) in working-age adults (18–64 years) remain suboptimal.
doi.org
April 22, 2025 at 6:47 PM
Early childhood antibiotics and chronic pediatric conditions: a retrospective cohort study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Early childhood antibiotics and chronic pediatric conditions: a retrospective cohort study
Early-childhood antibiotic exposure has been implicated in the development of chronic pediatric conditions, but many studies leave concerns about unmeasured confounding. We evaluated associations between early-childhood antibiotic exposure and allergic, autoimmune, or neurodevelopmental/psychiatric conditions.
doi.org
April 22, 2025 at 6:45 PM
Is the Renal Protective Effect of Montelukast on Vancomycin due to its Anti-allergic Mechanism?
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Is the Renal Protective Effect of Montelukast on Vancomycin due to its Anti-allergic Mechanism?
Research has shown that montelukast (a leukotriene receptor antagonist) can alleviate vancomycin associated acute kidney injury (AKI).
doi.org
April 15, 2025 at 10:19 PM